RNA Detection Reagents - Cancer Early Screening Series

High-throughput molecular diagnostic reagents for clinical laboratory use. These reagents are designed to support molecular-level diagnostics and testing procedures in medical settings.

A series of diagnostic tests for pregnancy detection. These products provide rapid confirmation of pregnancy through various detection methodologies.

A comprehensive product line of diagnostic reagents designed for research institutions and scientific investigations. Supports pathogenic studies and epidemiological research across multiple infection types.

Molecular diagnostic reagent series designed for high-throughput detection of drug resistance in clinical samples. Part of Jiangsu Mole BioScience's comprehensive molecular diagnostics product line for identifying antimicrobial resistance patterns.

Proprietary ELISA reagents for early detection of neurodegenerative markers associated with Alzheimer's disease and age-related cognitive decline. This patented series represents the first domestically-developed solution for dementia biomarker detection.

Immunoassay reagents designed for prenatal screening and fetal health assessment. These products detect maternal and fetal biomarkers to evaluate pregnancy-related conditions and fetal well-being.

Specialized reagents used in molecular detection assays for identifying nucleic acid targets. These reagents are designed for use in PCR and other nucleic acid-based diagnostic testing protocols.

Molecular diagnostic test for cancer detection and tumor marker analysis. Supports early detection of various cancer types.

Clinically validated sequencing panels specifically designed for early-stage cancer detection through liquid biopsy analysis. Supports non-invasive screening and enables identification of disease at earlier stages to improve patient outcomes.

Multi-biomarker screening solution for early-stage cancer identification. Analyzes blood samples to detect cancer-associated molecular signatures. Facilitates timely clinical intervention and improved patient outcomes.

A targeted blood-based early detection service for specific cancer types utilizing gene methylation biomarkers. This clinical testing service is performed by BioChain's certified medical laboratory.

Ultra-high sensitivity early detection kit designed to identify cancer gene mutations. Enables early-stage cancer diagnosis through advanced genetic analysis technology.